[Form 4] FS Bancorp, Inc. Insider Trading Activity
Michael J. Mansfield, a director of FS Bancorp, Inc. (ticker FSBW), reported transactions on 08/15/2025 under the FS Bancorp, Inc. 2018 Equity Incentive Plan. The filing shows an award of 750 restricted shares and grant of 1,500 stock options (exercise price $40.14). The filing also reports a disposition of 4,186 common shares and an indirect holding of 14,620 shares held by an IRA. After the reported transactions, Mr. Mansfield beneficially owned 69,682 shares directly and reported 10,220 derivative securities beneficially owned. The restricted shares and options vest on August 15, 2026. The form is signed and dated 08/19/2025.
- Equity alignment: Director received restricted stock and options, aligning interests with shareholders through vesting
- Clear disclosure: Transaction dates, quantities, exercise price, and vesting date are explicitly reported
- Share disposal: Reporting shows a disposition of 4,186 common shares, reducing direct holdings
- Potential dilution: Grant of 1,500 options adds potential future dilution if exercised
Insights
TL;DR: Director received equity awards and exercised routine holdings adjustments under the company equity plan; vesting one year out.
The disclosure documents a typical director compensation event: an award of restricted stock and stock options under the 2018 Equity Incentive Plan, both vesting on August 15, 2026. The filing also records a small disposal of common shares and an IRA-held indirect position. For governance review, this is a standard equity compensation transaction with clear vesting terms and no immediate related-party purchase from the company or unusual acceleration disclosed. It does not indicate changes to board composition or extraordinary related-party arrangements.
TL;DR: Insider grant increases potential future dilution modestly; current holdings and option strike are disclosed.
The Form 4 shows a grant of 750 restricted shares and 1,500 options at a $40.14 strike, which increases the director's alignment with shareholder interests subject to vesting. The filing shows a direct beneficial ownership of 69,682 shares and 10,220 derivative securities after the transactions. The reported disposal of 4,186 shares and the IRA-held 14,620 shares are disclosed explicitly. Absent additional context on total outstanding shares, the absolute dilution impact appears limited and the transaction is routine in nature for director compensation.